The short answer
May reduce muscle damage or support lean mass in selected untrained, older, or catabolic populations.
- Evidence and scope
- Mixed evidence
This status does not grade the ingredient for every goal, outcome, or person.
- Important limitation
- Benefits are inconsistent in trained adults and do not establish longevity effects.
- Before deciding
- Short-term studies suggest low risk, but product quality and long-term data remain limited.
01 / PRACTICAL GUIDE
Dose, absorption, and combinations
These are indication-specific reference or studied ranges—not a personalized prescription. Start with the objective, then check the form, label, medicines, and health conditions.
Reference or studied range—not a personalized prescription. The product label or a clinician may specify a different dose.
Dose source ↗More is not automatically better. A clinician or product label may specify a different amount.
Water-soluble or readily water-dispersible. This does not mean excess is always harmless.
Take consistently; benefits are most plausible in untrained, older, or catabolic populations.
Do not substitute it for adequate protein and resistance training.
Dose and use links lead to primary or official source material. Search links are discovery tools, not proof that every returned paper applies.
02 / EVIDENCE
What the research says
We keep supportive, mixed, negative, safety, and contextual findings together. The headline never replaces the underlying papers.
These are audited counts for this JIVANA collection, not search-result totals. Participants are counted once when multiple papers use the same cohort; review papers are not added again to participant totals.
Open the research timelineResearch timeline+
Entries are ordered by publication year. A study period appears only when the source reports it.
Effects of HMB Supplementation on Older Adults with Sarcopenia
HMB improved several strength and performance measures beyond exercise, but not skeletal muscle mass. The sample was small and the result needs replication.
Study design and methods
- Design
- Randomized, double-blind, placebo-controlled trial
- Population
- 34 adults aged 60 or older with sarcopenia
- Intervention
- HMB or placebo twice daily; both groups performed resistance exercise twice weekly
- Outcome
- Grip strength, gait speed, chair stands, muscle quality, body composition, and inflammation
Funding or conflict note: The authors reported no commercial or financial conflict of interest.
Health Benefits of HMB Supplementation in Addition to Physical Exercise in Older Adults
Adding HMB to exercise had no or only very small effects on body composition, strength, or physical performance; cognition evidence was insufficient.
Study design and methods
- Design
- Systematic review and meta-analysis of 10 randomized trials
- Population
- 384 adults aged 50–80
- Intervention
- HMB plus exercise versus exercise without HMB
- Outcome
- Body composition, strength, physical performance, and cognition
Funding or conflict note: Some trials overlap the earlier older-adult synthesis, so this review is excluded from aggregate totals. Authors declared no conflict of interest.
A double-blind placebo controlled trial into the impacts of HMB supplementation and exercise in older adults
Training increased strength and muscle thickness in both groups, with no clear added HMB effect on strength, mass, or protein synthesis between groups.
Study design and methods
- Design
- Randomized, double-blind, placebo-controlled resistance-training trial
- Population
- 16 healthy older men
- Intervention
- HMB free acid 3 g/day or placebo during unilateral resistance training
- Outcome
- Muscle protein synthesis, thigh lean mass, muscle thickness, and strength
Funding or conflict note: One author was affiliated with Metabolic Technologies, Inc. The trial is represented in the 2019 exercise meta-analysis and is excluded from aggregate totals.
Effect of beta-hydroxy-beta-methylbutyrate supplementation on muscle loss in older adults
HMB modestly favored muscle-mass preservation, without a fat-mass effect. The review could not establish improvements in strength or physical function.
Study design and methods
- Design
- Systematic review and meta-analysis of seven randomized trials
- Population
- 287 adults aged 65 or older
- Intervention
- HMB-containing interventions versus control
- Outcome
- Muscle and fat mass
Unscreened discovery appendix—not evidence347 candidate publicationsSearch run: Aug 21, 2026
Complete for the displayed PubMed query at the search timestamp—not for all databases or every possible synonym. Candidates can be irrelevant, duplicate the same study, or report negative findings. They are never summed as evidence or participants until screened.
03 / SOURCES
Start with the source material
The live search is for discovery only. Search-result counts change and are not included in the audited totals above.
Recent PubMed discovery recordsDirect links to the first 12 records returned by the reproducible search. These are discovery candidates—not reviewed summaries or a count of supportive findings.
- HMB supplementation combined with high-intensity functional exercise supports aerobic capacity but not strength in trained and untrained males: a randomized controlled trial.Durkalec-Michalski K, Murawa M, Steffl M et al. · 2026 · Journal of the International Society of Sports Nutrition · PMID 42441818Open on PubMed ↗
- Effects of acute HMB-FA supplementation on antioxidant status and muscle damage in Elite Judoka: a randomized pilot trial.Tayebi SM, Mirzaei M, Stout JR · 2026 · Journal of the International Society of Sports Nutrition · PMID 42084797Open on PubMed ↗
- Calcium Beta-Hydroxy-Beta-Methylbutyrate-Enriched Nutritional Supplementation During Dietary Weight Loss in Adults With Obesity: A Randomized Controlled Trial.Jiang J, Liang Y, Wang R et al. · 2026 · Journal of cachexia, sarcopenia and muscle · PMID 42444106Open on PubMed ↗
- Human milk banking services: an umbrella review.O'Donovan R, Murphy M, Lehane E et al. · 2026 · Public health nutrition · PMID 42503469Open on PubMed ↗
- Does β-hydroxy-β-methylbutyrate (HMB) have an anti-inflammatory impact in critically ill patients? A secondary post hoc analysis of an RCT.Berger MM, Viana MV, Engelen MPKJ et al. · 2026 · Clinical nutrition (Edinburgh, Scotland) · PMID 42202485Open on PubMed ↗
- Exercise-nutrition prehabilitation attenuates lean body mass loss before gastrectomy: a randomized controlled trial.Yamamoto K, Shinno N, Omori T et al. · 2026 · Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · PMID 42068448Open on PubMed ↗
- Bioequivalence of a Fixed-Dose Combination of Relugolix, Estradiol, and Norethindrone Acetate: An Open-Label, Randomized, Fully Replicate Crossover Study in Healthy Postmenopausal Women Under Fasting Conditions.Kotadia R, Kumar S, Khuroo A et al. · 2026 · Clinical pharmacology in drug development · PMID 42319246Open on PubMed ↗
- Foods rich in anti-inflammatory components and anti-inflammatory supplements for the prevention and treatment of Sarcopenia in older adults: A systematic review and network meta-analysis.Li S, Li J, Ren K et al. · 2026 · Complementary therapies in medicine · PMID 41796642Open on PubMed ↗
- Protein Supplementation for Hip Fracture Recovery in Elderly Patients: A Randomized Controlled Trial.Kalantar SH, Poursalehian M, Donyazad M et al. · 2026 · Journal of orthopaedic trauma · PMID 41665352Open on PubMed ↗
- Combined creatine and HMB co-supplementation improves functional strength independent of muscle mass in physically active older adults: a randomized crossover trial.Ramos-Hernández R, Miguel-Ortega Á, Martínez-Ferrán M et al. · 2026 · GeroScience · PMID 41073834Open on PubMed ↗
- The Effect of β-Hydroxy-β-Methyl Butyrate (HMB) upon Acute Fed-State Muscle Protein Turnover in Older Men and Women: A Randomized Double-Blind Controlled Crossover Clinical Trial.Smith K, Abdullah H, Rudrappa S et al. · 2026 · Nutrients · PMID 42124050Open on PubMed ↗
- The effects of beta-hydroxy-beta-methylbutyrate on sarcopenia in stable decompensated cirrhosis: A pilot randomized controlled trial.Manasirisuk W, Jinchai J, Inthanon J et al. · 2026 · Clinical nutrition ESPEN · PMID 41544700Open on PubMed ↗
04 / EXPERT CONTEXT
Expert context—not evidence
Expert positions are dated context—not scientific evidence. They never raise the evidence status or become consensus by repetition.
No direct, source-verified endorsement is currently recorded. Research authorship or discussion alone is not treated as endorsement.